spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Kloeckner Pentaplast Announces Plans for New Lamination Facility

Kloeckner Metals

A state-of-the-art system will be used to produce laminated pharmaceutical films

Montabaur, Germany – June 7, 2016 – The Klöckner Pentaplast Group announced plans today to expand its high-barrier film lamination and coating capacities to reinforce the company’s commitment to the global pharmaceutical and medical industries. Beginning in early 2017, Klöckner Pentaplast will use a state-of-the-art system to produce Aclar® laminated pharmaceutical films from its site in Montabaur, Germany, a trusted source of high quality kp films for many industries. The new Montabaur line will be fully operational for the entire kp Pentapharm® Aclar® product range by the end of 2017.

As a result of this investment, the Klöckner Pentaplast facility in Bern, Switzerland will also have added capacity available to produce PVdC-coated high-barrier pharmaceutical films, while continuing to be a backup site for Aclar® lamination. The plan strengthens kp’s dedication to its global packaging customers by providing improved customer service and security of supply from multiple sites under a global DMF.

“This capacity expansion is part of Klöckner Pentaplast’s long-term strategy to leverage our global footprint to maximize improvements across the value chain, with a focus on being even more responsive to our pharmaceutical customers’ needs now and in the future,“ says Markus Pischulti, Business Director, Pharmaceutical Films EMEA.

About Klöckner Pentaplast Group

The Klöckner Pentaplast Group is a global leader in providing packaging, printing and specialty solutions serving the pharmaceutical, medical device, food, beverage and card markets among others. With a broad portfolio of rigid plastic films and services powered by innovation, Klöckner Pentaplast plays an integral role in the customer value chain by marketing and protecting product integrity, safety, consumer health and ultimately, brand reputation.

Klöckner Pentaplast continuously earns high EcoVadis ratings, indicating the company’s commitment to Corporate Social Responsibility throughout its global operations. kp’s practices rank in the top 8% of suppliers within the respective industry classification of plastics manufacturing and in the top 12% of over twenty thousand suppliers evaluated by EcoVadis. In benchmark comparison within the plastics manufacturing industry, kp is ahead of the industry average in all four areas assessed: Environment, Labor Practices, Fair Business Practices, and Responsible & Sustainable Procurement. Klöckner Pentaplast is among the top 5% of suppliers assessed in industry classification for Environmental Practices and in the top 9% of suppliers assessed in respective industry classification of Fair Business Practices. Visit www.kpfilms.com.
phone 01132 540 711
email enquiries@kloeckner.com
web www.kloecknermetalsuk.com/
email Kloeckner Metals UK, Valley Farm Road, Stourton, Leeds, LS10 1SD, UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>


White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

Industry Events

Cell Therapy Manufacturing & Gene Therapy Congress

4-6 December 2018, RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 4 - 6 December 2018 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy will provide you with the latest advice for transforming innovative research to prosperous cell & gene therapy manufacturing.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement